VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
686
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
137
Interactions with Platform & by Email
PARTICIPANTS
27
Unique # Participated
VALIDATIONS
12
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
102
PAGES
178
EDITION
9
PRICE
USD $4950
The U.S. Economy is Reinventing Itself to Weather Economic Storms.
Here's An Analytical Window into the Changing Opportunities.
Amid the COVID-19 crisis, the global market for Subcutaneous Immunoglobulin estimated at US$3.8 Billion in the year 2020, is projected to reach a revised size of US$9.3 Billion by 2027, growing at a CAGR of 13.5% over the period 2020-2027.Primary Immunodeficiency Diseases, one of the segments analyzed in the report, is projected to grow at a 14.6% CAGR to reach US$7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Secondary Immunodeficiency Diseases segment is readjusted to a revised 10.5% CAGR for the next 7-year period. This segment currently accounts for a 29.8% share of the global Subcutaneous Immunoglobulin market.
The Subcutaneous Immunoglobulin market in the U.S. is estimated at US$1.1 Billion in the year 2020. The country currently accounts for a 29.55% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.6 Billion in the year 2027 trailing a CAGR of 12.9% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.8% and 11.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR while Rest of European market (as defined in the study) will reach US$1.6 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 178-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Biotest AG; CSL Behring; Grifols International SA; Grifols SA; Kedrion SpA; Octapharma AG; Shire PLC
» Application (Primary Immunodeficiency Diseases, Secondary Immunodeficiency Diseases) » End-Use (Hospitals, Clinics, Homecare Settings)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Subcutaneous Immunoglobulin Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Subcutaneous Immunoglobulin Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Subcutaneous Immunoglobulin Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Subcutaneous Immunoglobulin Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Primary Immunodeficiency Diseases (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| Primary Immunodeficiency Diseases (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Primary Immunodeficiency Diseases (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Secondary Immunodeficiency Diseases (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025 |
| Secondary Immunodeficiency Diseases (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017 |
| Secondary Immunodeficiency Diseases (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 |
| Hospitals (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 |
| Hospitals (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017 |
| Hospitals (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Clinics (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025 |
| Clinics (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Clinics (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| Homecare Settings (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025 |
| Homecare Settings (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2009-2017 |
| Homecare Settings (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Subcutaneous Immunoglobulin Market Share (in %) by Company: 2019 & 2025 |
| United States Subcutaneous Immunoglobulin Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Subcutaneous Immunoglobulin Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017 |
| Subcutaneous Immunoglobulin Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| United States Subcutaneous Immunoglobulin Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025 |
| Subcutaneous Immunoglobulin Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017 |
| Subcutaneous Immunoglobulin Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025 |
| CANADA |
| Canadian Subcutaneous Immunoglobulin Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Subcutaneous Immunoglobulin Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Canadian Subcutaneous Immunoglobulin Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Canadian Subcutaneous Immunoglobulin Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Subcutaneous Immunoglobulin Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| Canadian Subcutaneous Immunoglobulin Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| JAPAN |
| Japanese Demand Estimates and Forecasts for Subcutaneous Immunoglobulin in US$ Million by Application: 2018 to 2025 |
| Japanese Subcutaneous Immunoglobulin Market in US$ Million by Application: 2009-2017 |
| Subcutaneous Immunoglobulin Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Subcutaneous Immunoglobulin in US$ Million by End-Use: 2018 to 2025 |
| Japanese Subcutaneous Immunoglobulin Market in US$ Million by End-Use: 2009-2017 |
| Subcutaneous Immunoglobulin Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025 |
| CHINA |
| Chinese Demand for Subcutaneous Immunoglobulin in US$ Million by Application: 2018 to 2025 |
| Subcutaneous Immunoglobulin Market Review in China in US$ Million by Application: 2009-2017 |
| Chinese Subcutaneous Immunoglobulin Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Chinese Demand for Subcutaneous Immunoglobulin in US$ Million by End-Use: 2018 to 2025 |
| Subcutaneous Immunoglobulin Market Review in China in US$ Million by End-Use: 2009-2017 |
| Chinese Subcutaneous Immunoglobulin Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| EUROPE |
| Market Facts & Figures |
| European Subcutaneous Immunoglobulin Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Subcutaneous Immunoglobulin Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Subcutaneous Immunoglobulin Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Subcutaneous Immunoglobulin Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Subcutaneous Immunoglobulin Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Subcutaneous Immunoglobulin Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| European Subcutaneous Immunoglobulin Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| European Subcutaneous Immunoglobulin Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Subcutaneous Immunoglobulin Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| European Subcutaneous Immunoglobulin Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| FRANCE |
| Subcutaneous Immunoglobulin Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 |
| French Subcutaneous Immunoglobulin Historic Market Review in US$ Million by Application: 2009-2017 |
| French Subcutaneous Immunoglobulin Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Subcutaneous Immunoglobulin Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025 |
| French Subcutaneous Immunoglobulin Historic Market Review in US$ Million by End-Use: 2009-2017 |
| French Subcutaneous Immunoglobulin Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| GERMANY |
| Subcutaneous Immunoglobulin Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| German Subcutaneous Immunoglobulin Market in Retrospect in US$ Million by Application: 2009-2017 |
| Subcutaneous Immunoglobulin Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| Subcutaneous Immunoglobulin Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025 |
| German Subcutaneous Immunoglobulin Market in Retrospect in US$ Million by End-Use: 2009-2017 |
| Subcutaneous Immunoglobulin Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025 |
| ITALY |
| Italian Demand for Subcutaneous Immunoglobulin in US$ Million by Application: 2018 to 2025 |
| Subcutaneous Immunoglobulin Market Review in Italy in US$ Million by Application: 2009-2017 |
| Italian Subcutaneous Immunoglobulin Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Italian Demand for Subcutaneous Immunoglobulin in US$ Million by End-Use: 2018 to 2025 |
| Subcutaneous Immunoglobulin Market Review in Italy in US$ Million by End-Use: 2009-2017 |
| Italian Subcutaneous Immunoglobulin Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 |
| UNITED KINGDOM |
| United Kingdom Demand Estimates and Forecasts for Subcutaneous Immunoglobulin in US$ Million by Application: 2018 to 2025 |
| United Kingdom Subcutaneous Immunoglobulin Market in US$ Million by Application: 2009-2017 |
| Subcutaneous Immunoglobulin Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Subcutaneous Immunoglobulin in US$ Million by End-Use: 2018 to 2025 |
| United Kingdom Subcutaneous Immunoglobulin Market in US$ Million by End-Use: 2009-2017 |
| Subcutaneous Immunoglobulin Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025 |
| REST OF EUROPE |
| Rest of Europe Subcutaneous Immunoglobulin Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Subcutaneous Immunoglobulin Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Rest of Europe Subcutaneous Immunoglobulin Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Rest of Europe Subcutaneous Immunoglobulin Addressable Market Opportunity in US$ Million by End-Use: 2018-2025 |
| Subcutaneous Immunoglobulin Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017 |
| Rest of Europe Subcutaneous Immunoglobulin Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| ASIA-PACIFIC |
| Subcutaneous Immunoglobulin Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 |
| Asia-Pacific Subcutaneous Immunoglobulin Historic Market Review in US$ Million by Application: 2009-2017 |
| Asia-Pacific Subcutaneous Immunoglobulin Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Subcutaneous Immunoglobulin Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025 |
| Asia-Pacific Subcutaneous Immunoglobulin Historic Market Review in US$ Million by End-Use: 2009-2017 |
| Asia-Pacific Subcutaneous Immunoglobulin Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 |
| REST OF WORLD |
| Rest of World Subcutaneous Immunoglobulin Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Subcutaneous Immunoglobulin Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Rest of World Subcutaneous Immunoglobulin Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Rest of World Subcutaneous Immunoglobulin Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025 |
| Subcutaneous Immunoglobulin Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017 |
| Rest of World Subcutaneous Immunoglobulin Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 4 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com